Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis

Authors: Paulien R Wermeling, Kees J Gorter, Henk F van Stel, Guy EHM Rutten

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

Type 2 diabetes patients have a decreased health-related quality of life compared to healthy persons, especially regarding physical functioning and well-being. Health-related quality of life is even lower in type 2 diabetes patients when other diseases co-exist. In contrast to earlier studies, we assessed the associations between the number and type of comorbidities and health status in well-controlled type 2 diabetes patients, in whom treatment goals for HbA1c, blood pressure and cholesterol had been reached. Approximately one in five type 2 diabetes patients belongs to this group.

Methods

Cross-sectional analysis was performed in 2086 well-controlled (HbA1c ≤58 mmol/mol, systolic blood pressure ≤145 mmHg, total cholesterol ≤5.2 mmol/l and not using insulin) type 2 diabetes patients in general practice. Both number and type (cardiovascular and non-cardiovascular) of comorbidities were determined for each patient. Health status was assessed with the questionnaires Short Form-36 (SF-36) and EuroQol (EQ). The SF-36 generates eight dimensions of health and a Physical and Mental Component Score (PCS and MCS), scale: 0–100. The EQ consists of two parts: EQ-5D and EQ Visual Analogue Scale. Multivariable linear regression analysis was used to assess if number and type of comorbidities were associated with health status.

Results

Well-controlled type 2 diabetes patients with comorbidities had a much lower health status, with a decrease ranging from -1.5 for the MCS to -26.3 for role limitations due to physical problems, compared to those without. Health status decreased when the number of comorbidities increased, except for mental health, role limitations due to emotional problems, MCS and both EQ measures. In patients with both cardiovascular and non-cardiovascular comorbidity, physical functioning, role limitations due to physical problems and PCS were significantly lower than in patients with only cardiovascular comorbidity. Physical functioning was also lower compared to patients with only non-cardiovascular comorbidity.

Conclusions

Even acceptable values of HbA1c, blood pressure and cholesterol in type 2 diabetes patients are not necessarily related with a good health status. We have shown that comorbidities have a large impact on health status. Physicians may take into account patient’s health status and integrate the impact of comorbidities into diabetes care.
Literature
1.
go back to reference Rubin RR, Peyrot M: Quality of life and diabetes. Diabetes Metab Res Rev. 1999, 15: 205-218. 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O.CrossRefPubMed Rubin RR, Peyrot M: Quality of life and diabetes. Diabetes Metab Res Rev. 1999, 15: 205-218. 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O.CrossRefPubMed
2.
go back to reference Wandell PE: Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care. 2005, 23: 68-74. 10.1080/02813430510015296.CrossRefPubMed Wandell PE: Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries. Scand J Prim Health Care. 2005, 23: 68-74. 10.1080/02813430510015296.CrossRefPubMed
3.
go back to reference Rejeski WJ, Lang W, Neiberg RH, van Dorsten B, Foster GD, Maciejewski ML, et al: Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. Obesity (Silver Spring). 2006, 14: 870-883. 10.1038/oby.2006.101.CrossRef Rejeski WJ, Lang W, Neiberg RH, van Dorsten B, Foster GD, Maciejewski ML, et al: Correlates of health-related quality of life in overweight and obese adults with type 2 diabetes. Obesity (Silver Spring). 2006, 14: 870-883. 10.1038/oby.2006.101.CrossRef
4.
go back to reference Rijken M, van Kerkhof M, Dekker J, Schellevis FG: Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning. Qual Life Res. 2005, 14: 45-55. 10.1007/s11136-004-0616-2.CrossRefPubMed Rijken M, van Kerkhof M, Dekker J, Schellevis FG: Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning. Qual Life Res. 2005, 14: 45-55. 10.1007/s11136-004-0616-2.CrossRefPubMed
5.
go back to reference Laiteerapong N, Karter AJ, Liu JY, Moffet HH, Sudore R, Schillinger D, et al: Correlates of quality of life in older adults with diabetes: the diabetes & aging study. Diabetes Care. 2011, 34: 1749-1753. 10.2337/dc10-2424.PubMedCentralCrossRefPubMed Laiteerapong N, Karter AJ, Liu JY, Moffet HH, Sudore R, Schillinger D, et al: Correlates of quality of life in older adults with diabetes: the diabetes & aging study. Diabetes Care. 2011, 34: 1749-1753. 10.2337/dc10-2424.PubMedCentralCrossRefPubMed
6.
go back to reference Verma SK, Luo N, Subramaniam M, Sum CF, Stahl D, Liow PH, et al: Impact of depression on health related quality of life in patients with diabetes. Ann Acad Med Singapore. 2010, 39: 913-917.PubMed Verma SK, Luo N, Subramaniam M, Sum CF, Stahl D, Liow PH, et al: Impact of depression on health related quality of life in patients with diabetes. Ann Acad Med Singapore. 2010, 39: 913-917.PubMed
7.
go back to reference Quah JH, Luo N, Ng WY, How CH, Tay EG: Health-related quality of life is associated with diabetic complications, but not with short-term diabetic control in primary care. Ann Acad Med Singapore. 2011, 40: 276-286.PubMed Quah JH, Luo N, Ng WY, How CH, Tay EG: Health-related quality of life is associated with diabetic complications, but not with short-term diabetic control in primary care. Ann Acad Med Singapore. 2011, 40: 276-286.PubMed
8.
go back to reference Maddigan SL, Feeny DH, Majumdar SR, Farris KB, Johnson JA: Understanding the determinants of health for people with type 2 diabetes. Am J Public Health. 2006, 96: 1649-1655. 10.2105/AJPH.2005.067728.PubMedCentralCrossRefPubMed Maddigan SL, Feeny DH, Majumdar SR, Farris KB, Johnson JA: Understanding the determinants of health for people with type 2 diabetes. Am J Public Health. 2006, 96: 1649-1655. 10.2105/AJPH.2005.067728.PubMedCentralCrossRefPubMed
9.
go back to reference Wee HL, Cheung YB, Li SC, Fong KY, Thumboo J: The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?. Health Qual Life Outcomes. 2005, 3: 2-10.1186/1477-7525-3-2.PubMedCentralCrossRefPubMed Wee HL, Cheung YB, Li SC, Fong KY, Thumboo J: The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?. Health Qual Life Outcomes. 2005, 3: 2-10.1186/1477-7525-3-2.PubMedCentralCrossRefPubMed
10.
go back to reference Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, et al: Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006, 49: 1489-1497. 10.1007/s00125-006-0249-9.CrossRefPubMed Wexler DJ, Grant RW, Wittenberg E, Bosch JL, Cagliero E, Delahanty L, et al: Correlates of health-related quality of life in type 2 diabetes. Diabetologia. 2006, 49: 1489-1497. 10.1007/s00125-006-0249-9.CrossRefPubMed
11.
go back to reference Miksch A, Hermann K, Rolz A, Joos S, Szecsenyi J, Ose D, et al: Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany - a cross-sectional survey. Health Qual Life Outcomes. 2009, 7: 19-10.1186/1477-7525-7-19.PubMedCentralCrossRefPubMed Miksch A, Hermann K, Rolz A, Joos S, Szecsenyi J, Ose D, et al: Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany - a cross-sectional survey. Health Qual Life Outcomes. 2009, 7: 19-10.1186/1477-7525-7-19.PubMedCentralCrossRefPubMed
12.
go back to reference Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K: The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010, 26: 75-89. 10.1002/dmrr.1065.CrossRefPubMed Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K: The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010, 26: 75-89. 10.1002/dmrr.1065.CrossRefPubMed
13.
go back to reference Ose D, Wensing M, Szecsenyi J, Joos S, Hermann K, Miksch A: Impact of primary care-based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity. Diabetes Care. 2009, 32: 1594-1596. 10.2337/dc08-2223.PubMedCentralCrossRefPubMed Ose D, Wensing M, Szecsenyi J, Joos S, Hermann K, Miksch A: Impact of primary care-based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity. Diabetes Care. 2009, 32: 1594-1596. 10.2337/dc08-2223.PubMedCentralCrossRefPubMed
14.
go back to reference Imayama I, Plotnikoff RC, Courneya KS, Johnson JA: Determinants of quality of life in type 2 diabetes population: the inclusion of personality. Qual Life Res. 2011, 20: 551-558. 10.1007/s11136-010-9772-8.CrossRefPubMed Imayama I, Plotnikoff RC, Courneya KS, Johnson JA: Determinants of quality of life in type 2 diabetes population: the inclusion of personality. Qual Life Res. 2011, 20: 551-558. 10.1007/s11136-010-9772-8.CrossRefPubMed
15.
go back to reference Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA: Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006, 6: 84-10.1186/1472-6963-6-84.PubMedCentralCrossRefPubMed Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA: Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006, 6: 84-10.1186/1472-6963-6-84.PubMedCentralCrossRefPubMed
16.
go back to reference Cleveringa FG, Gorter KJ, van den Donk M, Rutten GE: Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care. Diabetes Care. 2008, 31: 2273-2275. 10.2337/dc08-0312.PubMedCentralCrossRefPubMed Cleveringa FG, Gorter KJ, van den Donk M, Rutten GE: Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care. Diabetes Care. 2008, 31: 2273-2275. 10.2337/dc08-0312.PubMedCentralCrossRefPubMed
17.
go back to reference Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A, et al: Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet. 2011, 378: 156-167. 10.1016/S0140-6736(11)60698-3.PubMedCentralCrossRefPubMed Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A, et al: Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet. 2011, 378: 156-167. 10.1016/S0140-6736(11)60698-3.PubMedCentralCrossRefPubMed
18.
go back to reference American Diabetes Association: Standards of medical care in diabetes--2012. Diabetes Care. 2012, 35 (1): S11-S63. American Diabetes Association: Standards of medical care in diabetes--2012. Diabetes Care. 2012, 35 (1): S11-S63.
19.
go back to reference Wermeling PR, van den Donk M, Gorter KJ, de Wit GA, van der Graaf Y, Rutten GEHM: Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial: Design of a randomised controlled patient-preference equivalence trial in primary care. BMC Fam Pract. 2010, 11: 35-10.1186/1471-2296-11-35.PubMedCentralCrossRefPubMed Wermeling PR, van den Donk M, Gorter KJ, de Wit GA, van der Graaf Y, Rutten GEHM: Towards a more efficient diabetes control in primary care: six-monthly monitoring compared with three-monthly monitoring in type 2 diabetes - The EFFIMODI trial: Design of a randomised controlled patient-preference equivalence trial in primary care. BMC Fam Pract. 2010, 11: 35-10.1186/1471-2296-11-35.PubMedCentralCrossRefPubMed
20.
go back to reference Rutten GEHM, De Grauw WJC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, et al: NHG-standaard Diabetes mellitus type 2 [article in Dutch]. Huisarts Wet. 2006, 49: 137-152. Rutten GEHM, De Grauw WJC, Nijpels G, Goudswaard AN, Uitewaal PJM, Van der Does FEE, et al: NHG-standaard Diabetes mellitus type 2 [article in Dutch]. Huisarts Wet. 2006, 49: 137-152.
21.
go back to reference Bradley C: Importance of differentiating health status from quality of life. Lancet. 2001, 357: 7-8. 10.1016/S0140-6736(00)03562-5.CrossRefPubMed Bradley C: Importance of differentiating health status from quality of life. Lancet. 2001, 357: 7-8. 10.1016/S0140-6736(00)03562-5.CrossRefPubMed
22.
go back to reference Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed
23.
go back to reference Brooks R: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed Brooks R: EuroQol: the current state of play. Health Policy. 1996, 37: 53-72. 10.1016/0168-8510(96)00822-6.CrossRefPubMed
24.
go back to reference Brooks R, Rabin R, de Charro F: The measurement and valuation of health status using EQ-5D: a European perspective. 2003, Dordrecht: Kluwer Academic PublishersCrossRef Brooks R, Rabin R, de Charro F: The measurement and valuation of health status using EQ-5D: a European perspective. 2003, Dordrecht: Kluwer Academic PublishersCrossRef
25.
go back to reference Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998, 51: 1055-1068. 10.1016/S0895-4356(98)00097-3.CrossRefPubMed Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998, 51: 1055-1068. 10.1016/S0895-4356(98)00097-3.CrossRefPubMed
26.
go back to reference Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health survey manual and interpretation guide. 1993, Boston, MA: The Health Institute, New England Medical Center, Ref Type: Report Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health survey manual and interpretation guide. 1993, Boston, MA: The Health Institute, New England Medical Center, Ref Type: Report
27.
go back to reference Ware JEJ, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user’s manual. 1994, Boston, MA: The Health Institute, New England Medical Center, Ref Type: Report Ware JEJ, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user’s manual. 1994, Boston, MA: The Health Institute, New England Medical Center, Ref Type: Report
28.
go back to reference Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006, 15: 1121-1132. 10.1002/hec.1124.CrossRefPubMed Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006, 15: 1121-1132. 10.1002/hec.1124.CrossRefPubMed
29.
go back to reference Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D: Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004, 2: 51-10.1186/1477-7525-2-51.PubMedCentralCrossRefPubMed Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D: Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004, 2: 51-10.1186/1477-7525-2-51.PubMedCentralCrossRefPubMed
30.
go back to reference Rubin DB: Multiple imputation for nonresponse in surveys. 1987, New York: WileyCrossRef Rubin DB: Multiple imputation for nonresponse in surveys. 1987, New York: WileyCrossRef
31.
go back to reference Cohen J: Statistical power analysis for the behavioral sciences. 1988, Hillsdale: Lawrence Erlbaum Associates, Second Cohen J: Statistical power analysis for the behavioral sciences. 1988, Hillsdale: Lawrence Erlbaum Associates, Second
32.
go back to reference Lustman PJ, Anderson RJ, Freedland KE, De GM, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000, 23: 934-942. 10.2337/diacare.23.7.934.CrossRefPubMed Lustman PJ, Anderson RJ, Freedland KE, De GM, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000, 23: 934-942. 10.2337/diacare.23.7.934.CrossRefPubMed
33.
go back to reference Leosdottir M, Willenheimer R, Persson M, Nilsson PM: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmo Preventive Project. Cardiovasc Diabetol. 2011, 10: 118-10.1186/1475-2840-10-118.PubMedCentralCrossRefPubMed Leosdottir M, Willenheimer R, Persson M, Nilsson PM: The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: a cross-sectional analysis within the Malmo Preventive Project. Cardiovasc Diabetol. 2011, 10: 118-10.1186/1475-2840-10-118.PubMedCentralCrossRefPubMed
34.
go back to reference Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002, 25: 458-463. 10.2337/diacare.25.3.458.CrossRefPubMed Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW: Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care. 2002, 25: 458-463. 10.2337/diacare.25.3.458.CrossRefPubMed
35.
go back to reference Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D: Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Publ Health. 2007, 7: 186-10.1186/1471-2458-7-186.CrossRef Papadopoulos AA, Kontodimopoulos N, Frydas A, Ikonomakis E, Niakas D: Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Publ Health. 2007, 7: 186-10.1186/1471-2458-7-186.CrossRef
36.
go back to reference Werkorganisatie Transparante Ketenzorg: Transparantie Ketenzorg Diabetes Mellitus: Rapportage zorggroepen 2010 [in Dutch]. 2012, Adviesgroep Ketenzorg and LVG, Ref Type: Report Werkorganisatie Transparante Ketenzorg: Transparantie Ketenzorg Diabetes Mellitus: Rapportage zorggroepen 2010 [in Dutch]. 2012, Adviesgroep Ketenzorg and LVG, Ref Type: Report
37.
go back to reference Nishimura R, Nakagami T, Sone H, Ohashi Y, Tajima N: Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial. Cardiovasc Diabetol. 2011, 10: 58-10.1186/1475-2840-10-58.PubMedCentralCrossRefPubMed Nishimura R, Nakagami T, Sone H, Ohashi Y, Tajima N: Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial. Cardiovasc Diabetol. 2011, 10: 58-10.1186/1475-2840-10-58.PubMedCentralCrossRefPubMed
38.
go back to reference Egede LE, Gebregziabher M, Lynch CP, Gilbert GE, Echols C: Longitudinal ethnic differences in multiple cardiovascular risk factor control in a cohort of US adults with diabetes. Diabetes Res Clin Pract. 2011, 94: 385-394. 10.1016/j.diabres.2011.08.003.CrossRefPubMed Egede LE, Gebregziabher M, Lynch CP, Gilbert GE, Echols C: Longitudinal ethnic differences in multiple cardiovascular risk factor control in a cohort of US adults with diabetes. Diabetes Res Clin Pract. 2011, 94: 385-394. 10.1016/j.diabres.2011.08.003.CrossRefPubMed
39.
go back to reference Frei A, Herzog S, Woitzek K, Held U, Senn O, Rosemann T, et al: Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care. Cardiovasc Diabetol. 2012, 11: 70-10.1186/1475-2840-11-70.PubMedCentralCrossRefPubMed Frei A, Herzog S, Woitzek K, Held U, Senn O, Rosemann T, et al: Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care. Cardiovasc Diabetol. 2012, 11: 70-10.1186/1475-2840-11-70.PubMedCentralCrossRefPubMed
40.
go back to reference Higashi T, Wenger NS, Adams JL, Fung C, Roland M, McGlynn EA, et al: Relationship between number of medical conditions and quality of care. N Engl J Med. 2007, 356: 2496-2504. 10.1056/NEJMsa066253.CrossRefPubMed Higashi T, Wenger NS, Adams JL, Fung C, Roland M, McGlynn EA, et al: Relationship between number of medical conditions and quality of care. N Engl J Med. 2007, 356: 2496-2504. 10.1056/NEJMsa066253.CrossRefPubMed
41.
go back to reference Ose D, Miksch A, Urban E, Natanzon I, Szecsenyi J, Kunz CU et al: Health related quality of life and comorbidity. A descriptive analysis comparing EQ-5D dimensions of patients in the German disease management program for type 2 diabetes and patients in routine care. BMC Health Serv Res. 2011, 11: 179-10.1186/1472-6963-11-179.PubMedCentralCrossRefPubMed Ose D, Miksch A, Urban E, Natanzon I, Szecsenyi J, Kunz CU et al: Health related quality of life and comorbidity. A descriptive analysis comparing EQ-5D dimensions of patients in the German disease management program for type 2 diabetes and patients in routine care. BMC Health Serv Res. 2011, 11: 179-10.1186/1472-6963-11-179.PubMedCentralCrossRefPubMed
42.
go back to reference Frei A, Chmiel C, Schlapfer H, Birnbaum B, Held U, Steurer J, et al: The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. Cardiovasc Diabetol. 2010, 9: 23-10.1186/1475-2840-9-23.PubMedCentralCrossRefPubMed Frei A, Chmiel C, Schlapfer H, Birnbaum B, Held U, Steurer J, et al: The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. Cardiovasc Diabetol. 2010, 9: 23-10.1186/1475-2840-9-23.PubMedCentralCrossRefPubMed
43.
go back to reference Debussche X, Collin F, Fianu A, Balcou-Debussche M, Fouet-Rosiers I, Koleck M, et al: Structured self-management education maintained over two years in insufficiently controlled type 2 diabetes patients: the ERMIES randomised trial in Reunion Island. Cardiovasc Diabetol. 2012, 11: 91-10.1186/1475-2840-11-91.PubMedCentralCrossRefPubMed Debussche X, Collin F, Fianu A, Balcou-Debussche M, Fouet-Rosiers I, Koleck M, et al: Structured self-management education maintained over two years in insufficiently controlled type 2 diabetes patients: the ERMIES randomised trial in Reunion Island. Cardiovasc Diabetol. 2012, 11: 91-10.1186/1475-2840-11-91.PubMedCentralCrossRefPubMed
44.
go back to reference Berthold HK, Bestehorn KP, Jannowitz C, Krone W, Gouni-Berthold I: Disease management programs in type 2 diabetes: quality of care. Am J Manag Care. 2011, 17: 393-403.PubMed Berthold HK, Bestehorn KP, Jannowitz C, Krone W, Gouni-Berthold I: Disease management programs in type 2 diabetes: quality of care. Am J Manag Care. 2011, 17: 393-403.PubMed
45.
go back to reference Fullerton B, Erler A, Pohlmann B, Gerlach FM: Predictors of dropout in the German disease management program for type 2 diabetes. BMC Health Serv Res. 2012, 12: 8-10.1186/1472-6963-12-8.PubMedCentralCrossRefPubMed Fullerton B, Erler A, Pohlmann B, Gerlach FM: Predictors of dropout in the German disease management program for type 2 diabetes. BMC Health Serv Res. 2012, 12: 8-10.1186/1472-6963-12-8.PubMedCentralCrossRefPubMed
46.
47.
go back to reference Maatouk I, Wild B, Wesche D, Herzog W, Raum E, Muller H, et al: Temporal predictors of health-related quality of life in elderly people with diabetes: results of a German cohort study. PLoS One. 2012, 7: e31088-10.1371/journal.pone.0031088.PubMedCentralCrossRefPubMed Maatouk I, Wild B, Wesche D, Herzog W, Raum E, Muller H, et al: Temporal predictors of health-related quality of life in elderly people with diabetes: results of a German cohort study. PLoS One. 2012, 7: e31088-10.1371/journal.pone.0031088.PubMedCentralCrossRefPubMed
Metadata
Title
Both cardiovascular and non-cardiovascular comorbidity are related to health status in well-controlled type 2 diabetes patients: a cross-sectional analysis
Authors
Paulien R Wermeling
Kees J Gorter
Henk F van Stel
Guy EHM Rutten
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-121

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.